SCHEMBL7984495

SCHEMBL7984495

CC(C)Cn1cnc2nc(-c3ccccc3)[nH]c(=O)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.47
PDE5A O76074 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
ADORA2A P29274 2/20 0.43
TLR7 Q9NYK1 2/20 0.43
POLB P06746 2/20 0.43
PDE4D Q08499 2/20 0.43
LMNA P02545 1/20 0.43
HRH2 P25021 1/20 0.43
ADRA1D P25100 1/20 0.43
HTR2A P28223 1/20 0.43
ADRA1A P35348 1/20 0.43
NUDT1 P36639 1/20 0.43
HTR2B P41595 1/20 0.43
KCNH2 Q12809 1/20 0.43
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ADORA2B P29275 1/20 0.42
TNKS O95271 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988488 0.86 BRD4 (0.50) HPGDPDE5AKMT2AMEN1ADORA2A
SCHEMBL7984998 0.84 PDE5A (0.52) HPGDPDE5AKMT2AMEN1ADORA2A
SCHEMBL7975265 0.82 SMN1; SMN2 (0.61) HPGDKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL7988249 0.81 PDE5A (0.50) HPGDPDE5AKMT2AMEN1ADORA2A
SCHEMBL7985373 0.81 PDE5A (0.49) HPGDPDE5AKMT2AMEN1ADORA2A
SCHEMBL7974613 0.80 CNOT7 (0.49) HPGDPDE5AKMT2APOLBLMNA
SCHEMBL7984499 0.80 ADORA2A (0.43) ADORA2ATLR7POLBPDE4DLMNA
SCHEMBL7974064 0.80 XDH (0.48) HPGDPDE5AKMT2AMEN1ADORA2A
SCHEMBL7984786 0.80 SMN1; SMN2 (0.45) HPGDPDE5AKMT2AMEN1POLB
SCHEMBL7984716 0.80 SMN1; SMN2 (0.53) HPGDPDE5AKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed